MAPT and Alzheimer disease: Though UPRmt was activated in both 2D and 3D PITRM1 KO models, only PITRM1 KO cerebral organoids displayed the typical abnormalities observed in the brains of AD patients, including neuronal cell death, tau pathology, and the accumulation of protein aggregates, similar to Aβ plaques.